Novo Nordisk to enter RNA market with Dicerna purchaseDenmark's Novo Nordisk, the world's leading insulin maker, has revealed it will buy US-based Dicerna Pharmaceuticals, a developer of RNA...
GLP-1s associated with higher risk of major depression, increased risk for anxiety and an elevated risk for suicidal behaviour1 day ago